IQVIA™ Pharma Deals: Review and Analysis

IQVIA Pharma Deals Review

ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.

Pharma Deals Review Latest Articles

Novartis Licenses Mesoblast’s Stem Cell Therapy Remestemcel-L Published: 24 Nov-2020
By: Michelle Liu
Abstract Fulltext:
Volume: 2020 Issue: 11
Novo Nordisk Acquires Emisphere’s Eligen® Technology for US$1.8 B Published: 19 Nov-2020
By: Michelle Liu
Abstract Fulltext:
Volume: 2020 Issue: 11
Merck & Co. Continues Oncology Expansion with US$2.75 B VelosBio Buy Published: 17 Nov-2020
By: Michelle Liu
Abstract Fulltext:
Volume: 2020 Issue: 11
Acadia Buys Pain Management Specialist CerSci Therapeutics for US$940 M Published: 31 Oct-2020
By: Ashish Tripathi & Michelle Liu
Abstract Fulltext:
Volume: 2020 Issue: 10
Dyno Therapeutics Signs US$1.8 B Gene Therapy Pact with Roche Published: 30 Oct-2020
By: Pratika Pahwa & Michelle Liu
Abstract Fulltext:
Volume: 2020 Issue: 10

Adobe Flash Player Required

You will need version 7 or above of the FREE Adobe Flash Player plugin, click on the logo below to download

You can click on any of the bars to open a new page with the corresponding deals.

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

Latest Article

Novartis Licenses Mesoblast’s Stem Cell Therapy Remestemcel-L

Published: 24 Nov-2020
By: Michelle Liu Abstract Fulltext:

HALF-YEAR DEAL REVIEW OF 2020

Click Here to Access the Article

IQVIA™ Pharma Deals: Review and Analysis